The haplotype-haplotype interaction showed that G10 (MAU2 G-A-G-C) and G6 (CILP2 G-T) carriers could reduce the risk of hyperlipidemia compared with G10 or G6 carriers. The gene discussed is MAU2; the disease is hyperlipidemia.